Abeona Therapeutics Management
Management criteria checks 2/4
Abeona Therapeutics' CEO is Vish Seshadri, appointed in Oct 2021, has a tenure of 2.58 years. total yearly compensation is $2.85M, comprised of 19.5% salary and 80.5% bonuses, including company stock and options. directly owns 1.97% of the company’s shares, worth €2.30M. The average tenure of the management team and the board of directors is 2.5 years and 3.2 years respectively.
Key information
Vish Seshadri
Chief executive officer
US$2.8m
Total compensation
| CEO salary percentage | 19.5% |
| CEO tenure | 2.6yrs |
| CEO ownership | 2.0% |
| Management average tenure | 2.5yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$555k | -US$54m |
| Sep 30 2023 | n/a | n/a | -US$45m |
| Jun 30 2023 | n/a | n/a | -US$39m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$1m | US$505k | -US$43m |
| Sep 30 2022 | n/a | n/a | -US$83m |
| Jun 30 2022 | n/a | n/a | -US$84m |
| Mar 31 2022 | n/a | n/a | -US$91m |
| Dec 31 2021 | US$2m | US$255k | -US$85m |
Compensation vs Market: Vish's total compensation ($USD2.85M) is above average for companies of similar size in the German market ($USD399.70K).
Compensation vs Earnings: Vish's compensation has increased whilst the company is unprofitable.
CEO
Vish Seshadri (47 yo)
2.6yrs
Tenure
US$2,847,442
Compensation
Dr. Vishwas Seshadri, also known as Vish, Ph.D. & M.B.A., serves as Chief Executive Officer, President and Director at Abeona Therapeutics Inc. since October 15, 2021. He served as the Senior Vice Presiden...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.6yrs | US$2.85m | 1.97% $ 2.3m | |
| Chief Financial Officer | 2.2yrs | US$1.49m | 0.85% $ 999.3k | |
| Senior VP & General Counsel | 4.1yrs | US$1.17m | 0.69% $ 806.4k | |
| Senior VP | 2.9yrs | no data | no data | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Vice President of Human Resources | 2.3yrs | no data | no data | |
| VP & Head of Quality | 2.6yrs | no data | no data | |
| Chief Medical Officer | 1.3yrs | no data | no data | |
| Senior VP | less than a year | no data | no data | |
| Senior Vice President of Regulatory Affairs | no data | no data | no data |
2.5yrs
Average Tenure
50yo
Average Age
Experienced Management: PCJ's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.6yrs | US$2.85m | 1.97% $ 2.3m | |
| Independent Director | 3.2yrs | US$336.14k | 0.21% $ 250.8k | |
| Independent Director | 3.2yrs | US$336.14k | 0.29% $ 334.7k | |
| Independent Director | 3.1yrs | US$330.52k | 0.27% $ 321.2k | |
| Independent Director | 4.2yrs | US$324.89k | 0.25% $ 297.8k | |
| Independent Director | 3.1yrs | US$336.14k | 0.25% $ 290.3k | |
| Member of Scientific Advisory Board | 7.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.1yrs | no data | no data | |
| Chairman of the Board | 3.2yrs | US$351.14k | 0.29% $ 341.1k |
3.2yrs
Average Tenure
49.5yo
Average Age
Experienced Board: PCJ's board of directors are considered experienced (3.2 years average tenure).